SCHEMBL6689464

SCHEMBL6689464

CCCCCC(CCCCC)C(=O)O.CCCCCCCCC(C)CC(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.58
GPR84 Q9NQS5 7/20 0.55
GRIK1 P39086 2/20 0.53
GRIK2 Q13002 2/20 0.53
CA2 P00918 2/20 0.50
SLC1A2 P43004 1/20 0.50
SLC1A1 P43005 1/20 0.50
MAPK1 P28482 1/20 0.50
FFAR1 O14842 1/20 0.48
MAPT P10636 1/20 0.47
LCK P06239 1/20 0.47
PPARD Q03181 1/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.47
ZDHHC2 Q9UIJ5 1/20 0.47
CHRM1 P11229 1/20 0.47
AKR1A1 P14550 1/20 0.47
CHRM3 P20309 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
ADRA1A P35348 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1872991 0.91 GPR84 (0.64) ACE2GPR84FFAR1MAPTLCK
SCHEMBL3305087 0.91 GPR84 (0.64) ACE2GPR84FFAR1MAPTLCK
SCHEMBL2343127 0.91 GPR84 (0.64) ACE2GPR84FFAR1MAPTLCK
SCHEMBL22612526 0.91 GPR84 (0.64) ACE2GPR84FFAR1MAPTLCK
SCHEMBL22612511 0.91 GPR84 (0.64) ACE2GPR84FFAR1MAPTLCK
SCHEMBL23930717 0.91 GPR84 (0.64) ACE2GPR84FFAR1MAPTLCK
SCHEMBL17772493 0.91 GPR84 (0.64) ACE2GPR84FFAR1MAPTLCK
SCHEMBL22240 0.91 GPR84 (0.64) ACE2GPR84FFAR1MAPTLCK
SCHEMBL7823853 0.91 GPR84 (0.64) ACE2GPR84FFAR1MAPTLCK
SCHEMBL8049901 0.91 GPR84 (0.64) ACE2GPR84FFAR1MAPTLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0925792-B1 Insoluble insulin compositions for controlling blood glucose LILLY CO ELI (US) 2004-04-21 EP disclosed
EP-1396272-A1 Insoluble Insulin Compositions for Controlling Blood Glucose Eli Lilly & Company (US) 2004-03-10 EP disclosed
US-20030144181-A1 Insoluble compositions for controlling blood glucose BRADER MARK LAURENCE (US) 2003-07-31 US disclosed
EP-0925792-A2 Insoluble compositions for controlling blood glucose ELI LILLY AND COMPANY (US) 1999-06-30 EP disclosed